XXII
What one share of 22nd Century Group holds
Cigarettes
We manufacture and distribute the only combustible tobacco products containing minimally or non-addictive levels of nicotine that are authorized by the US Food and Drug Administration (FDA) for retail purchase.
22nd Century Group’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $59.56 |
|---|---|
| Profit | −$141.64 |
| Capex (buildings and equipment) | $1.61 |
| Free cash flow | −$35.91 |
| Cash and investments | $12.05 |
| Debt | $1.11 |
| Book value | $37.07 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.31 | −$2.25 | — | −$1.86 | — | $4.02 |
| 2017 | $2.46 | −$1.93 | — | −$1.79 | — | $9.16 |
| 2018 | $3.19 | −$0.90 | — | −$2.15 | — | $8.58 |
| 2019 | $3.08 | −$3.16 | $0.06 | −$1.80 | — | $6.73 |
| 2020 | $3.04 | −$2.13 | $0.01 | −$1.69 | — | $4.76 |
| 2021 | $2.97 | −$3.13 | $0.07 | −$2.26 | — | $6.09 |
| 2022 | $3.15 | −$4.65 | $0.28 | −$4.31 | — | $6.69 |
| 2025 | $95.55 | −$52.88 | $0.33 | −$42.29 | — | $612.94 |